Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michal London"'
Autor:
Gilad W. Vainer, Judith Sandbank, Yaniv Zohar, Tzahi Neuman, Juliane Kania-Almog, Michal London, Iris Barshak, Anna Litvin, Ludmila Fridel
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 11(11)
Immunotherapy is a novel treatment for lung cancer. Pembrolizumab (Merck Sharp and Dohme, Kenilworth, NJ) is a monoclonal antibody against programmed cell death 1 that has been approved for use with NSCLC together with a companion diagnostic by Dako
Autor:
Rachel Levy, Maya Iohan Barak, Michal London, Yaron Bar-Dayan, Noga Boldor, Yosefa Bar-Dayan, Inbar Kremer
Publikováno v:
Journal of Emergencies, Trauma and Shock
Background : The willingness of healthcare workers to risk their lives for a patient with a potentially fatal, communicable disease is a major concern, especially during a pandemic where the need for adequate staffing is crucial and where the public